The Economist @TheEconomist
Firms involved in developing CRISPR editing for use in medicines have downplayed concerns about the process https://t.co/4ntjYJ5kDJ — PolitiTweet.org
Created
Sat Jun 15 19:40:06 +0000 2019
Likes
37
Retweets
16
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The Economist @TheEconomist
Firms involved in developing CRISPR editing for use in medicines have downplayed concerns about the process https://t.co/4ntjYJ5kDJ — PolitiTweet.org